Search Results - Pandya, Shuchi Sumant

INDIGO: a global, randomized, double-blinded, phase 3 study of vorasidenib versus placebo in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation. by Van den Bent, Martin J. (Author) , Blumenthal, Deborah T. (Author) , Touat, Mehdi (Author) , Peters, Katherine B. (Author) , Clarke, Jennifer Leigh (Author) , Mendez, Joe Sammy (Author) , Welsh, Liam (Author) , Mason, Warren P. (Author) , Hottinger, Andreas Felix (Author) , Sanchez, Juan Manuel Sepulveda (Author) , Wick, Wolfgang (Author) , Soffietti, Riccardo (Author) , Schoenfeld, Steven (Author) , Zhao, Dan (Author) , Pandya, Shuchi Sumant (Author) , Steelman, Lori (Author) , Hassan, Islam (Author) , Wen, Patrick Y. (Author) , Cloughesy, Timothy Francis (Author) ,

• Verlag, kostenfrei, Volltext
• Verlag, kostenfrei, Volltext